Literature DB >> 8026196

Metabolic effects of a D-beta-hydroxybutyrate infusion in septic patients: inhibition of lipolysis and glucose production but not leucine oxidation.

M Beylot1, D Chassard, C Chambrier, M Guiraud, M Odeon, B Beaufrère, P Bouletreau.   

Abstract

OBJECTIVE: To study the effect of a D-beta-hydroxybutyrate infusion on protein metabolism, lipolysis, and endogenous glucose production in septic patients.
DESIGN: Prospective, randomized trial.
SETTING: Intensive care unit (ICU) and metabolic unit at a university hospital. PATIENTS: Twelve ICU patients with sepsis and six healthy normal subjects.
INTERVENTIONS: Septic patients were administered 4-hr infusions of either D-beta-hydroxybutyrate or a control solution, 12 hrs after parenteral nutrition was replaced with an isotonic saline infusion.
MEASUREMENTS AND MAIN RESULTS: The appearance and oxidation rates of leucine (L[1-13C]leucine) and endogenous glucose production (D[6,6-2H2]glucose), plasma fatty acids, and glycerol values were measured before and at the end of infusion of D-beta-hydroxybutyrate or control solution. Unlike the control test, the D-beta-hydroxybutyrate infusion decreased glucose production, fatty acids, and glycerol concentrations, but failed to decrease the leucine oxidation rate.
CONCLUSION: Exogenous ketone-bodies infusion decreased lipolysis and glucose production in septic patients but had no beneficial effect on protein metabolism, as evaluated with L[1-13C]leucine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026196     DOI: 10.1097/00003246-199407000-00007

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.

Authors:  Yonglin Chen; Xinshou Ouyang; Rafaz Hoque; Irma Garcia-Martinez; Muhammad Nadeem Yousaf; Sarah Tonack; Stefan Offermanns; Laurent Dubuquoy; Alexandre Louvet; Philippe Mathurin; Veronica Massey; Bernd Schnabl; Ramon Alberola Bataller; Wajahat Zafar Mehal
Journal:  J Hepatol       Date:  2018-04-27       Impact factor: 25.083

Review 2.  Exogenous Ketone Supplements in Athletic Contexts: Past, Present, and Future.

Authors:  Mark Evans; Tyler S McClure; Andrew P Koutnik; Brendan Egan
Journal:  Sports Med       Date:  2022-10-10       Impact factor: 11.928

Review 3.  Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?

Authors:  Lise Van Wyngene; Jolien Vandewalle; Claude Libert
Journal:  EMBO Mol Med       Date:  2018-08       Impact factor: 12.137

4.  The Effects of a 6-Week Controlled, Hypocaloric Ketogenic Diet, With and Without Exogenous Ketone Salts, on Body Composition Responses.

Authors:  Alex Buga; Madison L Kackley; Christopher D Crabtree; Teryn N Sapper; Lauren Mccabe; Brandon Fell; Rich A LaFountain; Parker N Hyde; Emily R Martini; Jessica Bowman; Yue Pan; Debbie Scandling; Milene L Brownlow; Annalouise O'Connor; Orlando P Simonetti; William J Kraemer; Jeff S Volek
Journal:  Front Nutr       Date:  2021-03-24

5.  Exogenous d-β-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis.

Authors:  Adrian Soto-Mota; Nicholas G Norwitz; Rhys D Evans; Kieran Clarke
Journal:  Endocrinol Diabetes Metab       Date:  2021-11-16

6.  Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control.

Authors:  Adrian Soto-Mota; Nicholas G Norwitz; Rhys Evans; Kieran Clarke; Thomas M Barber
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.